Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2012
11/14/2012CN102775339A Preparation method of N-methyl-2-chloroethylpyrrolidine
11/14/2012CN102249976B Preparation method of optically pure (-)-clausenamide compound
11/14/2012CN102190611B Method for purifying N-methyl pyrrolidone and gamma-butyrolactone
11/14/2012CN102180824B Method for preparing pyrrole derivative
11/14/2012CN101821235B Pyrrolidin-2 -one derivatives as androgen receptor modulator
11/14/2012CN101671357B (S)-Alpha, Alpha-fluorine-containing diaryl-2-pyrrolidine methanol derivative as well as preparation and applications thereof
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/14/2012CN101484405B Dehydroxylated fluorinating agent
11/14/2012CN101395131B Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
11/13/2012US8309740 One-pot synthesis of fluorinated ionic liquids
11/13/2012US8309715 Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012CA2505299C Novel biaromatic compunds which activate ppary type receptors, and use therof in cosmetic or pharmaceutical compositions
11/08/2012US20120283448 Method for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/08/2012US20120283266 Lysine specific demethylase-1 inhibitors and their use
11/07/2012EP2520566A1 New Pharmaceutical Compounds
11/07/2012EP2519499A1 Pesticidal arylpyrrolidines
11/07/2012CN102770163A Iodine radiolabelling method
11/07/2012CN102766080A Pyrrolidine derivative, its preparation method and application thereof
11/07/2012CN102766079A Pyrrolidine derivative, its preparation method and application thereof
11/07/2012CN102766004A Method for synthesizing aminoacyl arylamine
11/07/2012CN102229555B Method for preparing N-phenyl succinimide
11/07/2012CN102030695B Method for preparing bactericide N-(2,4,6-trichlorophenyl) maleimide
11/07/2012CN101268047B Crystalline and amorphous sodium atorvastatin
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/07/2012CN101117328B Fatty acid synthetase inhibitor and application for treating bacterial infection
11/06/2012US8304561 Synthetic route to ABCD-porphyrins
11/06/2012US8304447 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
11/06/2012US8304445 7-pyrazolyl tetracycline compounds and methods of use thereof
11/06/2012US8304419 Chemical compounds
11/06/2012US8304410 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
11/06/2012CA2563269C Process for producing cyclic n-hydroxy imide compounds
11/01/2012WO2012148599A1 Germanosilicate ssz-75
11/01/2012WO2012146515A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012145808A1 Method for preparing atorvastatin calcium using new intermediates and resulting atorvastatin
11/01/2012WO2012071291A3 Oil release with n-lauroyl amino acid-based compounds
11/01/2012US20120277420 Refined routes to chlorin building blocks
11/01/2012US20120277405 Copolymer of pyrene and pyrrole and method of producing the copolymer
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277250 Amidine-containing compounds useful as muscarinic receptor antagonists
11/01/2012US20120276018 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012CA2834467A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012CA2829218A1 Germanosilicate ssz-75
10/2012
10/31/2012EP2517706A2 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/31/2012EP2516416A1 Crth2 modulators
10/31/2012EP2516393A1 Carboxamide compounds and their use as calpain inhibitors
10/31/2012EP2516392A1 Substituted benzamide derivatives
10/31/2012CN1768149B Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives
10/31/2012CN102762200A Chalcones as enhancer of antimicrobial agents
10/31/2012CN102757376A Preparation method of b-heterocyclic ketone compound
10/31/2012CN102757370A Derivatives of p-aminobenzoic acid and applications thereof
10/31/2012CN102190610B Method for separating and purifying kainic acid through controllable multichannel electroosmosis
10/31/2012CN101845011B (S)-prolineamide type derivative, preparation method and application thereof
10/31/2012CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof
10/30/2012US8299271 Solid tartrate salts of DPP-IV inhibitors
10/30/2012US8299115 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
10/30/2012US8299096 Method for treating pulmonary diseases using rho kinase inhibitor compounds
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299058 Spiro-condensed indoline derivatives as pesticides
10/30/2012US8298326 Tricyclic spacer systems for nonlinear optical devices
10/30/2012CA2581730C New histone deacetylases inhibitors
10/30/2012CA2560964C Synthesis of pyrrole-2-carbonitriles
10/30/2012CA2556078C Carboxamides
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012143660A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012WO2012143468A1 3,4-disubstituted pyrrole 2,5-diones and their use as fungicides
10/26/2012CA2833339A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/25/2012US20120271057 Synthetic processes for the preparation of aminocyclohexyl ether compounds
10/25/2012US20120271049 Bifunctional phenyl iso (thio) cyanates, processes and intermediates products for their preparation
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269750 Cosmetic compositions comprising an ester derived from 4-carboxy-2-pyrrolidinone and a lipophilic screening agent; use of said derivative as a solvent for a benzophenone lipophilic screening agent
10/25/2012US20120269749 Cosmetic compositions comprising an ester derived from 4-carboxy-2-pyrrolidinone and a merocyanin screening agent; use of said derivative as a solvent for a merocyanin screening agent
10/24/2012EP2514743A1 Immunosuppressant Compounds and Compositions
10/24/2012EP2513053A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512639A1 Analysis of amino acids and amine-containing compounds using tagging reagents and lc-ms workflow
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012EP2512461A1 Chalcones as enhancer of antimicrobial agents
10/24/2012CN102753523A Functionalized n-substituted pyrrolidonium ionic liquids
10/24/2012CN102753522A Substituted pyrrolidine-2-carboxamides
10/24/2012CN102746278A Chiral pseudonucleoside compound and its preparation method and use
10/24/2012CN102746209A A synthetic method for 3-(2-(4-chlorophenoxy)phenyl )-1-methyl-2,4-dione
10/24/2012CN102746208A Economic preparation method of 4-bromine-2-aryl-5-trifluoromethyl-1H-pyrrole-3-nitrile
10/24/2012CN102746207A Synthesis method of oxiracetam
10/24/2012CN102134212B Preparation method of Oxiracetam
10/24/2012CN101815702B Novel crystalline form
10/23/2012US8293943 Prevention of cellular senescence in mammals by natural peptide complexes
10/23/2012US8293926 Method of producing optically active 4-amino-3-substituted phenylbutanoic acid
10/23/2012US8293925 Pyrrolidinone carboxamide derivatives
10/23/2012US8293770 Pyrrolidine derivatives as NK-3 receptor antagonists
10/23/2012CA2566526C Naphthaline derivatives useful as histamine-3-receptor ligands
10/18/2012WO2012142308A1 Prodrugs of inhibitors of plasma kallikrein
10/18/2012WO2012139775A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
10/18/2012US20120264949 Method of Labeling Dopamine D2 Receptor Using Radiosynthesized Ligand of Iodine-123-Epidepride
10/18/2012US20120264939 Fluoride-Releasing Compositions
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 404